— Know what they know.
Not Investment Advice

CALA OTC

Calithera Biosciences, Inc.
1W: -66.7% 1M: -66.7% 3M: -75.0% YTD: +0.0% 1Y: +0.0% 3Y: -99.8% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±115.6%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 51 · $487 mcap · 5M float · 0.010% daily turnover · Short 47% of daily vol

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 6Hold: 4Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2022-11-14 Leerink Partners — Initiated $2 — -29.1% $2.82

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
0
Earnings Quality
30
Growth
48
Value
41
Momentum
50
Safety
0
Cash Flow
—

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-27.91
Distress Zone
Piotroski F-Score
1/9
✗ ✗ ✓ ✗ ✗ ✗ ✗ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
3.69
Bankruptcy prob: 97.6%
High Risk
Credit Rating
B+
Score: 33.5/100
Trend: Improving
Earnings Quality
—
OCF/NI: 2.14x
Accruals: 49.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CALA scores -27.91, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CALA scores 1/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CALA's implied 97.6% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CALA receives an estimated rating of B+ (score: 33.5/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.00x
PEG
-0.00x
P/S
0.00x
P/B
0.00x
P/FCF
-0.36x
P/OCF
—
EV/EBITDA
0.19x
EV/Revenue
—
EV/EBIT
0.19x
EV/FCF
0.18x
Earnings Yield
-128.31%
FCF Yield
-275.63%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CALA currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.514
NI / EBT
×
Interest Burden
0.942
EBT / EBIT
×
EBIT Margin
—
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
3.247
Assets / Equity
=
ROE
-141.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CALA's ROE of -141.5% is driven by A tax burden ratio of 0.51 suggests the company retains less than 60% of pre-tax earnings after taxes.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.00
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
639.9%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Susan Molineaux, Ph.D.
President and Chief Executive Officer
$589,200 $253,300 $1,988,987
Stephanie Wong Financial
ancial Officer & Secretary
$413,700 $551,300 $1,492,689
Eric Sjogren, Ph.D.
Senior Vice President, Drug Discovery
$400,500 $536,400 $1,386,358
Keith Orford, M.D.,
Ph.D. Former Chief Medical Officer
$416,101 $551,300 $1,372,586

CEO Pay Ratio

1:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $1,988,987
Avg Employee Cost (SGA/emp): $1,519,500
Employees: 8

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
8
-87.3% YoY
Revenue / Employee
—
Profit / Employee
$-2,358,250
NI: $-18,866,000
SGA / Employee
$1,519,500
Avg labor cost proxy
R&D / Employee
$3,566,625
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
ROE -22.6% -21.5% -31.4% -39.4% -51.3% -60.2% -68.3% -66.8% -77.6% -61.5% -73.4% -73.6% -77.6% -70.7% -69.5% -3.0% -3.5% -2.3% -2.6% -1.4% -1.42%
ROA -17.6% -17.9% -26.1% -32.6% -41.9% -53.0% -59.6% -57.7% -64.4% -52.4% -60.7% -61.2% -66.1% -60.9% -57.6% -1.7% -2.0% -1.9% -2.1% -43.6% -43.59%
ROIC 9.6% -4.9% 6.9% 4.8% 31.3% 14.4% 16.5% 10.9% 27.9% 20.4% 9.0% 11.9% 13.9% 11.5% 8.1% 1.9% 1.9% 20.0% 14.5% 9.8% 9.80%
ROCE -25.3% -24.1% -35.5% -44.8% -59.6% -60.6% -70.9% -62.3% -69.9% -60.0% -71.3% -85.3% -89.9% -94.4% -90.1% -1.3% -1.5% -1.5% -1.9% -2.0% -1.98%
Gross Margin 1.0% 1.0% — — — — — — — — — — — 1.0% 1.0% — — — — — —
Operating Margin -2.7% -21.9% — — — — — — — — — — — -4.8% -1.7% — — — — — —
Net Margin -2.5% -18.0% — — — — — — — — — — — -4.8% -1.7% — — — — — —
EBITDA Margin -2.7% -21.9% — — — — — — — — — — — -4.7% -1.6% — — — — — —
FCF Margin -1.4% -1.6% -2.1% -2.9% -4.1% — — — — — — — — -24.2% -6.6% -6.8% -6.2% -9.0% — — —
OCF Margin -1.4% -1.6% -2.1% -2.9% -4.1% — — — — — — — — -24.1% -6.5% -6.8% -6.2% -9.0% — — —
ROE 3Y Avg snapshot only -7.22%
ROE 5Y Avg snapshot only -4.55%
ROA 3Y Avg snapshot only -1.33%
ROIC Economic snapshot only -1.51%
Cash ROA snapshot only -1.52%
Valuation
Metric Trend Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
P/E Ratio -0.32 -0.27 -0.21 -0.14 -0.20 -0.09 -0.09 -0.17 -0.16 -0.21 -0.14 -0.19 -0.10 -0.10 -0.12 -0.02 -0.01 -0.10 -0.11 -0.78 -0.000
P/S Ratio 0.42 0.24 0.32 0.35 0.77 — — — — — — — — 2.58 0.83 0.26 0.16 2.08 — — 0.000
P/B Ratio 0.08 0.06 0.07 0.06 0.12 0.06 0.07 0.11 0.11 0.13 0.10 0.17 0.09 0.09 0.11 0.30 -0.51 0.40 0.54 0.78 0.000
P/FCF -0.30 -0.15 -0.15 -0.12 -0.19 -0.11 -0.11 -0.20 -0.17 -0.22 -0.15 -0.21 -0.11 -0.11 -0.13 -0.04 -0.03 -0.23 -0.24 -0.36 -0.363
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA 3.71 3.72 2.72 2.25 1.40 1.54 1.29 1.44 1.25 1.44 1.30 1.00 1.04 1.01 1.07 0.84 0.70 0.47 0.34 0.19 0.189
EV/Revenue -5.18 -3.60 -4.47 -5.77 -5.54 — — — — — — — — -26.93 -7.49 -5.54 -4.14 -3.76 — — —
EV/EBIT 3.70 3.71 2.71 2.24 1.39 1.53 1.29 1.44 1.24 1.44 1.30 1.00 1.04 1.00 1.06 0.84 0.70 0.46 0.33 0.19 0.188
EV/FCF 3.71 2.28 2.09 1.97 1.34 1.91 1.57 1.69 1.36 1.55 1.49 1.08 1.14 1.11 1.14 0.81 0.67 0.42 0.29 0.18 0.181
Earnings Yield -3.1% -3.7% -4.8% -7.1% -5.0% -10.7% -10.5% -5.7% -6.3% -4.7% -7.3% -5.2% -9.8% -10.3% -8.5% -66.5% -100.5% -9.6% -9.3% -1.3% -1.28%
FCF Yield -3.3% -6.5% -6.6% -8.5% -5.4% -8.8% -8.9% -5.0% -5.9% -4.5% -6.6% -4.9% -9.1% -9.4% -7.9% -26.6% -38.1% -4.3% -4.2% -2.8% -2.76%
Price/Tangible Book snapshot only 0.778
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Current Ratio 5.27 13.66 13.66 9.42 6.75 8.06 7.39 8.14 8.75 9.88 7.07 6.45 7.72 7.53 6.38 4.39 4.16 4.81 3.76 3.60 3.603
Quick Ratio 5.27 13.66 13.66 9.42 6.75 8.06 7.39 8.17 8.94 9.88 7.07 6.45 7.72 7.53 6.38 4.39 4.16 4.81 3.76 3.60 3.603
Debt/Equity 0.00 0.00 0.00 0.00 0.09 0.06 0.07 0.06 0.06 0.05 0.06 0.07 0.04 0.04 0.05 0.36 -0.86 0.07 0.08 0.08 0.082
Net Debt/Equity -1.02 -0.96 -1.04 -1.07 -1.02 -1.03 -1.04 -1.05 -1.02 -1.02 -1.07 -1.06 -1.05 -1.07 -1.09 -6.74 — -1.12 -1.21 -1.17 -1.166
Debt/Assets 0.00 0.00 0.00 0.00 0.07 0.05 0.06 0.05 0.05 0.04 0.05 0.05 0.03 0.04 0.04 0.05 0.05 0.05 0.05 0.06 0.058
Debt/EBITDA -0.00 -0.00 -0.00 -0.00 -0.14 -0.10 -0.10 -0.09 -0.08 -0.08 -0.08 -0.07 -0.04 -0.05 -0.05 -0.05 -0.05 -0.04 -0.04 -0.04 -0.040
Net Debt/EBITDA 4.01 3.97 2.92 2.38 1.59 1.63 1.39 1.61 1.40 1.65 1.44 1.19 1.14 1.10 1.18 0.88 0.73 0.72 0.61 0.57 0.568
Interest Coverage — — — — — — — — — — — — — -20159.50 -2649.50 -2391.04 -1600.47 -1708.94 -5306.20 -4674.89 -4674.889
Equity Multiplier 1.21 1.08 1.09 1.13 1.24 1.19 1.21 1.18 1.17 1.15 1.20 1.23 1.18 1.18 1.21 7.73 -16.02 1.29 1.41 1.41 1.406
Cash Ratio snapshot only 3.444
Debt Service Coverage snapshot only -4653.667
Cash to Debt snapshot only 15.277
FCF to Debt snapshot only -26.255
Defensive Interval snapshot only 222.7 days
Efficiency & Turnover
Metric Trend Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Asset Turnover 0.13 0.20 0.17 0.13 0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.08 0.10 0.12 0.09 0.00 0.00 0.000
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 3.51 15.27 14.81 14.18 7.87 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.42 40.79 12.65 16.88 1125.00 0.00 — —
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.16 0.163
DSO 104 24 25 26 46 — — — — — — — — 57 9 29 22 0 — — —
DIO — — — — — — — — — — — — — — — — — — — 0 0.0 days
DPO — — — — — — — — — — — — — — — — — — — 2240 2240.1 days
Cash Conversion Cycle — — — — — — — — — — — — — — — — — — — — —
Fixed Asset Turnover snapshot only 0.000
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Revenue 5.4% 2.2% 57.8% -14.3% -36.7% -1.0% -1.0% -1.0% -1.0% — — — — — — — — 1.2% -1.0% -1.0% -1.00%
Net Income -4.2% -15.5% -74.8% -96.3% -83.7% -1.6% -90.1% -64.5% -39.2% -0.8% -1.9% -0.3% 5.0% 7.9% 23.4% -84.1% -85.1% -68.5% -95.0% 87.7% 87.73%
EPS 26.4% -13.8% -70.4% -82.1% -69.1% -1.2% -28.7% -14.5% 16.2% 40.1% 22.3% 21.8% 15.1% 13.5% 27.0% -73.2% -70.4% -9.5% -48.5% 90.5% 90.54%
FCF -4.3% -3.9% -5.1% -6.2% -87.8% -22.6% -17.8% -21.1% -20.4% -16.6% -7.3% -7.1% 6.8% 12.8% 19.9% 21.2% 23.8% 16.2% 4.9% 34.2% 34.17%
EBITDA -10.5% -21.1% -76.3% -93.8% -79.7% -1.5% -86.0% -61.7% -37.7% -0.4% -0.7% 1.5% 6.8% 9.7% 24.4% 29.4% 33.9% 32.2% 22.9% 34.8% 34.84%
Op. Income -9.6% -20.2% -75.1% -93.0% -79.8% -1.5% -86.6% -62.2% -37.9% -0.4% -0.6% 1.6% 6.9% 9.8% 24.4% -26.3% -24.6% -30.9% -50.9% 63.6% 63.55%
OCF Growth snapshot only 34.23%
Asset Growth snapshot only -55.72%
Equity Growth snapshot only 1.43%
Debt Growth snapshot only -45.20%
Shares Change snapshot only 29.77%
Growth (CAGR)
Metric Trend Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Revenue 3Y — — — — — — — — — — — — — -56.6% -30.9% -24.0% -17.0% — — — —
Revenue 5Y — — — — — — — — — — — — — — — — 18.4% -10.0% — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — -56.6% -30.9% -24.0% -17.0% — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — 18.4% -10.0% — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 22.6% 20.5% 20.4% 23.5% 22.6% 38.1% 35.4% 45.5% -12.6% -8.3% -10.4% -13.3% -14.7% -14.9% -15.2% -23.2% -27.5% -35.1% -36.7% -44.6% -44.61%
Assets 5Y — — — — — — — 10.0% 9.1% 12.7% 11.8% 10.6% 9.1% 9.1% 8.8% 3.4% -25.8% -26.6% -29.0% -31.7% -31.67%
Equity 3Y 16.7% 19.5% 20.0% 20.9% 16.4% 33.8% 30.9% 41.8% -8.3% -4.1% -8.1% -12.0% -14.0% -17.4% -18.2% -59.6% — -36.8% -39.8% -47.7% -47.69%
Book Value 3Y -7.3% -5.1% -4.9% -5.8% -9.3% 3.2% -6.7% 2.9% -32.9% -23.5% -26.9% -30.0% -31.9% -35.1% -35.5% -67.7% — -54.9% -50.6% -56.7% -56.74%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Revenue Stability 0.72 0.82 0.90 0.73 0.60 0.04 0.01 0.10 0.06 0.00 0.01 0.03 0.04 0.03 0.00 0.00 0.00 0.13 0.39 0.49 0.489
Earnings Stability 0.64 0.26 0.27 0.69 0.80 0.59 0.62 0.79 0.86 0.74 0.76 0.79 0.85 0.70 0.61 0.84 0.86 0.83 0.74 0.09 0.088
Margin Stability — — — — 1.00 — — — 1.00 — — — — — — — 1.00 1.00 — — —
Rev. Growth Consistency 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.98 0.94 0.50 0.50 0.50 0.50 0.50 0.50 0.84 1.00 0.99 1.00 0.98 0.97 0.91 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 0.12 0.18 0.08 0.04 -0.39 -0.42 -0.47 -0.32 -0.28 -0.18 -0.20 -0.35 -0.25 -0.35 -0.19 -19.04 — -3.04 -4.23 9.34 9.338
Gross Margin Trend — — — — 0.00 — — — — — — — — — — — — — — — —
FCF Margin Trend — — — — -4.82 — — — — — — — — — — — — — — — —
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
OCF/Net Income 1.03 1.71 1.35 1.19 1.08 0.83 0.85 0.88 0.94 0.96 0.89 0.94 0.92 0.91 0.93 0.40 0.38 0.45 0.45 2.14 2.142
FCF/OCF 1.03 1.02 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.003
FCF/Net Income snapshot only 2.148
CapEx/Revenue 4.5% 2.9% 2.5% 1.0% 1.1% — — — — — — — — 1.6% 1.5% 1.5% 1.5% 3.8% — — —
Accruals Ratio 0.01 0.13 0.09 0.06 0.03 -0.09 -0.09 -0.07 -0.04 -0.02 -0.07 -0.04 -0.05 -0.06 -0.04 -1.05 -1.23 -1.04 -1.15 0.50 0.498
Sloan Accruals snapshot only -0.562
Cash Flow Adequacy snapshot only -327.880
Dividends & Buybacks
Metric Trend Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -9.8% -15.7% -73.4% -1.8% -1.1% -8.7% -7.7% -6.2% -7.3% -4.5% -6.8% -1.9% -4.1% -32.2% -30.8% -4.3% -1.4% -74.2% -72.8% -1.1% -1.14%
Total Shareholder Return -9.8% -15.7% -73.4% -1.8% -1.1% -8.7% -7.7% -6.2% -7.3% -4.5% -6.8% -1.9% -4.1% -32.2% -30.8% -4.3% -1.4% -74.2% -72.8% -1.1% -1.14%
DuPont Factors
Metric Trend Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.44 1.47 1.31 1.31 0.51 0.514
Interest Burden (EBT/EBIT) 0.94 0.93 0.95 0.95 0.96 0.97 0.97 0.97 0.97 0.97 0.98 0.99 0.99 0.99 0.99 1.78 1.88 1.89 1.92 0.94 0.942
EBIT Margin -1.40 -0.97 -1.65 -2.57 -3.98 — — — — — — — — -26.88 -7.07 -6.62 -5.91 -8.10 — — —
Asset Turnover 0.13 0.20 0.17 0.13 0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.08 0.10 0.12 0.09 0.00 0.00 0.000
Equity Multiplier 1.28 1.20 1.20 1.21 1.22 1.14 1.15 1.16 1.21 1.17 1.21 1.20 1.17 1.16 1.21 1.72 1.77 1.21 1.26 3.25 3.247
Per Share
Metric Trend Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
EPS (Diluted TTM) $-19.81 $-18.58 $-25.33 $-28.50 $-33.50 $-41.73 $-32.59 $-32.64 $-28.07 $-24.99 $-25.31 $-25.54 $-23.83 $-21.61 $-18.47 $-44.22 $-40.61 $-23.66 $-27.43 $-4.18 $-4.18
Book Value/Share $82.66 $82.05 $74.67 $66.11 $54.53 $67.49 $44.88 $51.74 $39.55 $41.22 $34.75 $29.01 $26.07 $22.42 $20.08 $2.23 $-0.80 $6.19 $5.42 $4.19 $4.08
Tangible Book/Share $82.66 $82.05 $74.67 $66.11 $54.53 $67.49 $44.88 $51.74 $39.55 $41.22 $34.75 $29.01 $26.07 $22.42 $20.08 $2.23 $-0.80 $6.19 $5.42 $4.19 $4.19
Revenue/Share $15.07 $20.50 $16.21 $11.61 $8.78 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.81 $2.63 $2.60 $2.49 $1.18 $0.00 $0.00 $0.00
FCF/Share $-21.05 $-32.40 $-34.64 $-33.94 $-36.38 $-34.51 $-27.62 $-28.61 $-26.38 $-23.91 $-22.60 $-23.91 $-21.97 $-19.57 $-17.24 $-17.71 $-15.41 $-10.65 $-12.48 $-8.99 $-8.76
OCF/Share $-20.38 $-31.81 $-34.24 $-33.83 $-36.29 $-34.44 $-27.61 $-28.61 $-26.38 $-23.90 $-22.59 $-23.89 $-21.95 $-19.56 $-17.20 $-17.67 $-15.37 $-10.61 $-12.45 $-8.96 $-8.74
Cash/Share $84.39 $78.84 $77.71 $71.04 $60.21 $74.19 $49.69 $57.17 $42.79 $44.34 $39.05 $32.63 $28.47 $24.90 $22.80 $15.87 $11.38 $7.33 $7.00 $5.23 $5.10
EBITDA/Share $-21.04 $-19.87 $-26.64 $-29.82 $-34.79 $-42.93 $-33.54 $-33.57 $-28.84 $-25.60 $-25.73 $-25.79 $-24.02 $-21.69 $-18.51 $-17.14 $-14.62 $-9.56 $-10.87 $-8.60 $-8.60
Debt/Share $0.00 $0.00 $0.00 $0.00 $4.79 $4.33 $3.19 $2.98 $2.41 $2.12 $2.03 $1.90 $1.04 $0.99 $0.91 $0.81 $0.69 $0.42 $0.42 $0.34 $0.34
Net Debt/Share $-84.39 $-78.84 $-77.71 $-71.04 $-55.41 $-69.85 $-46.49 $-54.19 $-40.37 $-42.22 $-37.02 $-30.72 $-27.44 $-23.91 $-21.89 $-15.06 $-10.69 $-6.92 $-6.59 $-4.89 $-4.89
Per Employee
Metric Trend Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Employee Count snapshot only 8
Revenue/Employee snapshot only $0.00
Income/Employee snapshot only $-2545250.00
EBITDA/Employee snapshot only $-5235375.00
FCF/Employee snapshot only $-5467625.00
Assets/Employee snapshot only $3584500.00
Market Cap/Employee snapshot only $1983710.00
Academic Models
Metric Trend Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -27.914
Altman Z-Prime snapshot only -61.724
Piotroski F-Score 2 2 2 1 1 1 1 1 3 3 2 1 2 3 4 3 2 2 1 1 1
Beneish M-Score -3.32 -1.35 — — — — — — — — — — — — — — — — — — —
Ohlson O-Score snapshot only 3.689
ROIC (Greenblatt) snapshot only -2.00%
Net-Net WC snapshot only $3.77
Credit
Metric Trend Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Current
Credit Rating snapshot only B+
Credit Score 59.39 59.33 59.37 60.69 42.10 42.43 42.96 42.68 43.34 41.97 41.73 40.95 39.89 30.19 30.44 29.38 20.00 32.24 32.92 33.50 33.502
Credit Grade snapshot only 14
Credit Trend snapshot only 4.121
Implied Spread (bps) snapshot only 650.000
Industry Credit Rank snapshot only 27
Sector Credit Rank snapshot only 27

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms